Timothy M. Sullivan
Private Equity Investor presso VC23 Investors LLC
Profilo
Timothy M.
Sullivan is currently a Venture Partner at VC23 Investors LLC.
Previously, he worked as an Executive Director at Purdue Pharma LP from 1999 to 2002.
He then served as the Vice President-Development Programs at Idera Pharmaceuticals, Inc. from 2002 to 2010.
Prior to that, he held the position of Vice President-Eastern Operations at Oread, Inc. from 1997 to 1999.
Dr. Sullivan obtained his undergraduate degree from Michigan State University in 1975.
He later earned graduate and doctorate degrees from Purdue University in 1981.
Posizioni attive di Timothy M. Sullivan
| Società | Posizione | Inizio |
|---|---|---|
VC23 Investors LLC
 VC23 Investors LLC Investment ManagersFinance VC23 Investors LLC (VC23) is a venture capital firm founded in 1900. The firm is headquartered in Avon, Connecticut. | Private Equity Investor | - |
Precedenti posizioni note di Timothy M. Sullivan
| Società | Posizione | Fine |
|---|---|---|
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Corporate Officer/Principal | 01/01/2002 |
Oread, Inc.
 Oread, Inc. Pharmaceuticals: MajorHealth Technology Oread, Inc. operates in drug development and manufacturing operations. The private company is based in Lawrence, KS and has subsidiaries in the United States. | Corporate Officer/Principal | 01/01/1999 |
Idera Pharmaceuticals, Inc.
 Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Corporate Officer/Principal | - |
Formazione di Timothy M. Sullivan
| Michigan State University | Undergraduate Degree |
| Purdue University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA. | Health Technology |
Oread, Inc.
Oread, Inc. Pharmaceuticals: MajorHealth Technology Oread, Inc. operates in drug development and manufacturing operations. The private company is based in Lawrence, KS and has subsidiaries in the United States. | Health Technology |
Purdue Pharma LP
Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Health Technology |
VC23 Investors LLC
VC23 Investors LLC Investment ManagersFinance VC23 Investors LLC (VC23) is a venture capital firm founded in 1900. The firm is headquartered in Avon, Connecticut. | Finance |
- Borsa valori
- Insiders
- Timothy M. Sullivan
